Literature DB >> 29463666

Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management.

Yang T Du1,2, Christopher K Rayner2,3,4, Karen L Jones1,2,3, Nicholas J Talley5,6,7, Michael Horowitz8,2,3.   

Abstract

If you haven't measured something, you really don't know much about it.-Karl Pearson (attributed)Gastrointestinal (GI) symptoms represent an important and often unappreciated cause of morbidity in diabetes, although the significance of this burden across the spectrum of patients and the underlying pathophysiology, including the relationship of symptoms with glycemic control, remain poorly defined. The relevance of GI symptoms and the necessity for their accurate assessment have increased with the greater focus on the gut as a therapeutic target for glucose lowering. This review addresses the prevalence, assessment, pathogenesis, and management of GI symptoms in diabetes, beginning with broad principles and then focusing on specific segments of the GI tract. We initially performed a literature search of PubMed by using synonyms and combinations of the following search terms: "gastrointestinal symptoms", "diabetes", "prevalence", "pathogenesis", "diagnosis", and "management". We restricted the search results to English only. Review papers and meta-analyses are presented as the highest level of evidence where possible followed by randomized controlled trials, uncontrolled trials, retrospective and observational data, and expert opinion.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2018        PMID: 29463666     DOI: 10.2337/dc17-1536

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults.

Authors:  Tiansheng Wang; Jeff Y Yang; John B Buse; Virginia Pate; Huilin Tang; Edward L Barnes; Robert S Sandler; Til Stürmer
Journal:  Diabetes Care       Date:  2019-08-30       Impact factor: 19.112

Review 2.  Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control.

Authors:  Ryan J Jalleh; Karen L Jones; Christopher K Rayner; Chinmay S Marathe; Tongzhi Wu; Michael Horowitz
Journal:  Diabetologia       Date:  2022-10-04       Impact factor: 10.460

Review 3.  Lost-in-Translation of Metabolic Effects of Inorganic Nitrate in Type 2 Diabetes: Is Ascorbic Acid the Answer?

Authors:  Zahra Bahadoran; Parvin Mirmiran; Khosrow Kashfi; Asghar Ghasemi
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 4.  Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes.

Authors:  Md Kamruzzaman; Michael Horowitz; Karen L Jones; Chinmay S Marathe
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-09       Impact factor: 5.555

5.  Comparing radiopaque markers and 13C-labelled breath test in diabetic gastroparesis diagnostics.

Authors:  Dag A Sangnes; Eirik Søfteland; Tonje Teigland; Georg Dimcevski
Journal:  Clin Exp Gastroenterol       Date:  2019-05-07

Review 6.  Dietary SCFAs, IL-22, and GFAP: The Three Musketeers in the Gut-Neuro-Immune Network in Type 1 Diabetes.

Authors:  Abhirup Jayasimhan; Eliana Mariño
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

7.  Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance.

Authors:  Jaime P Almandoz; Ildiko Lingvay; Javier Morales; Carlos Campos
Journal:  Clin Diabetes       Date:  2020-10

Review 8.  Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy.

Authors:  Sai Laxmi M; Prabhakar O
Journal:  J Diabetes Metab Disord       Date:  2021-01-15

9.  Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy.

Authors:  Mette W Klinge; Nanna Sutter; Esben B Mark; Anne-Mette Haase; Per Borghammer; Vincent Schlageter; Sten Lund; Jesper Fleischer; Karoline Knudsen; Asbjørn M Drewes; Klaus Krogh
Journal:  J Neurogastroenterol Motil       Date:  2021-07-30       Impact factor: 4.924

10.  Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.

Authors:  Joseph L DeRisi; Mark S Anderson; Sara E Vazquez; Elise Mn Ferré; David W Scheel; Sara Sunshine; Brenda Miao; Caleigh Mandel-Brehm; Zoe Quandt; Alice Y Chan; Mickie Cheng; Michael German; Michail Lionakis
Journal:  Elife       Date:  2020-05-15       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.